Global M&A Intelligence Report 2025 – Life Sciences Supplement

Welcome to the second edition of the Life Sciences M&A Supplement, our bi-annual analysis of the trends, challenges, and opportunities in the global life sciences M&A market.

In this report, we delve into a selection of our international corporate life sciences transactions to identify trends and developments that can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically and internationally.

Our team of specialists have provided insights across the following key areas:

• Key Trends: The importance of intelligent technology, enhanced supply chain scrutiny, a continued focus on core assets, regulatory compliance, and the size of deals.
• Specialist Areas: The impact of US government affairs on trade, tax, and M&A, equity capital markets both within and outside the US, private equity, anti-trust, and venture capital.
• Jurisdictions: Jurisdictional and regional updates from key M&A markets, including Australia, China, France, Germany, the Middle East, the Nordics, the United Kingdom, and the United States.
• Warranty and Indemnity Insurance: The state of W&I in the sector, with updates on sector appetite, pricing trends, regulatory compliance, transaction structures, and industry-wide challenges.